SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-248755
Filing Date
2024-10-31
Accepted
2024-10-31 16:42:00
Documents
15
Period of Report
2024-10-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d840498d8k.htm   iXBRL 8-K 30385
2 EX-10.1 d840498dex101.htm EX-10.1 47279
3 EX-10.2 d840498dex102.htm EX-10.2 44832
  Complete submission text file 0001193125-24-248755.txt   277632

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA coya-20241028.xsd EX-101.SCH 2878
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20241028_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20241028_pre.xml EX-101.PRE 11726
17 EXTRACTED XBRL INSTANCE DOCUMENT d840498d8k_htm.xml XML 3768
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 241415809
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)